New technology cures genetic blood disorder in mice
A new gene-editing technology developed by Carnegie Mellon University and Yale University, has successfully cured a genetic blood disorder in living mice. The new therapeutic approach, which relies on peptide nucleic acid molecules, was administered using an intravenous treatment. This could aid the technology's use in treating blood related genetic diseases in humans like sickle cell disease.